| Literature DB >> 1985884 |
R Laskov1, R I Michaeli, H Sharir, E Yefenof, I Vlodavsky.
Abstract
The production of heparanase, an endoglycosidase capable of degrading heparan sulfate from the subendothelial extracellular matrix (ECM), was investigated in various murine B-lymphoid tumors representing distinct maturation stages of the B-cell lineage. We found that heparanase is produced and released by 3 out of 4 pre-B lymphomas and by 4 B lymphomas examined. In contrast, 5 plasmacytomas and resting normal B lymphocytes, expressed little, if any, heparanase activity. Treatment with LPS resulted in high expression of the enzyme by normal B-lymphocytes, but there was no effect on the constitutive production of heparanase by myeloma or B-lymphoma cells. Our results indicate that heparanase is produced by B cells during discrete stages of their maturation. We suggest that heparanase may play a role in B-cell migration by enabling pre-B and B lymphocytes to leave the bone-marrow compartment and recirculate among peripheral lymphoid organs.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1985884 DOI: 10.1002/ijc.2910470117
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396